News zu ADVICENNE (PROM.) EO-,20

Advicenne 2024 Universal Registration Document Made Available · Uhr · Business Wire
Advicenne Announces its 2025 Financial Calendar · Uhr · Business Wire
Advicenne Announces an 8.8% Increase in Gross Sales for H1 2024 and Provides an Update on Its Activities · Uhr · Business Wire
Advicenne Announces the Approval of All Resolutions Supported by the Board of Directors at Its Combined General Meeting · Uhr · Business Wire
Advicenne Announces Its 2024 Financial Calendar · Uhr · Business Wire
Advicenne Announces Long-Term Results of the European Clinical Development Program for ADV7103 · Uhr · Business Wire
Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting · Uhr · Business Wire
Advicenne 2022 Universal Registration Document Made Available · Uhr · Business Wire
Advicenne Announces the Second Tranche Drawdown of Its Non-dilutive Financing Agreement With the EIB · Uhr · Business Wire
Advicenne Announces Its Financial Calendar For 2023 · Uhr · Business Wire
Advicenne Announces Its Upcoming Participation in Two of the Most Important International Investor Conferences · Uhr · Business Wire
Advicenne 2021 Universal Registration Document Made Available · Uhr · Business Wire
Advicenne Announces the Release of Results of a Study Showing Improved Quality of Life in Patients Living With DRTa and Treated by ADV7103 · Uhr · Business Wire
Advicenne Ordinary Shareholders’ Meeting Approved the Project to Transfer Advicenne’s Shares Listing to the Euronext Growth Paris Market and Delisting From the Regulated Market of Euronext Brussels · Uhr · Business Wire
Advicenne Reports 2021 Sales up 20% to €3.3 Million · Uhr · Business Wire
Advicenne Announces Commercialization Agreement with FrostPharma AB for Sibnayal™ in the Nordic Region · Uhr · Business Wire
Advicenne Announces Its Financial Calendar for 2022 · Uhr · Business Wire
Advicenne Announces Positive Opinion From the French Transparency Commission (HAS) for its Drug Sibnayal™ in dRTA · Uhr · Business Wire
Advicenne Announces Significant Progress in Marketing Its Lead Product Sibnayal™ in Europe · Uhr · Business Wire
Proposed Transfer of the Listing of Advicenne’s Shares to the Euronext Growth Paris Market and Delisting From the Regulated Market of Euronext Brussels · Uhr · Business Wire